December 13, 2007 – A Canadian nuclear reactor that makes and distributes globally more than two-thirds of the world’s supply of radioisotopes for cancer tests, may reopen by Dec. 20, after being shut down since November.

Atomic Energy of Canada Ltd. (ACEL), a government-owned nuclear technology company that operates the reactor, shut it down after technical problems. Pending a push through emergency legislation allowing AECL to use a backup method, the reactor should be back to full production within seven days.

The Ontario Association of Nuclear Medicine says about 50,000 Canadians and 160,000 Americans would have their tests postponed for each month the reactor remains shut down.

The company says it could restart the reactor now using an emergency pump but the Canadian Nuclear Safety Commission does not agree. The government is trying to aim legislation to temporarily sideline the watchdog and allow the reactor to operate for 120 days.

For more information: www.aecl.ca


Additional Content

News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | FDA

Nov. 25, 2025 —Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

Time November 26, 2025
arrow
Sponsored Content | Videos | Radiology Business

Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...

Time October 09, 2025
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
Subscribe Now